Biperiden Hydrochloride

็›้…ธๆฏ”ๅ“Œ็ซ‹็™ป

Report date: 2023/07/28 20:00:50
NME

Base Information

Drug NameBiperiden Hydrochloride
Drug Alias Name็›้…ธๅฎ‰ๅ…‹็—‰Biperidenumๆฏ”ๅ“Œ็ซ‹็™ป็›้…ธ็›Biperidenoๅฎ‰ๅ…‹็—‰็›้…ธ็› +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsCocaine-Related DisordersEpilepsy, Post-TraumaticBrain Injuries, Traumatic +[5]ย 
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/09/08
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active IndicationsEpilepsy, Post-TraumaticBrain Injuries, TraumaticBrain Injuries
Inactive IndicationsCocaine-Related DisordersParkinson Disease

Other Information

ATC CodeN04AA02